SEATTLE–(BUSINESS WIRE)– #DryAMD–LumiThera, Inc. today announced the U.S. FDA has authorized marketing of Valeda® Light Delivery System for patients with dry AMD.
Author: Business Wire
Glaukos Announces Third Quarter 2024 Financial Results
ALISO VIEJO, Calif.–(BUSINESS WIRE)–Glaukos Corporation (NYSE: GKOS), an ophthalmic pharmaceutical and medical technology company focused on novel therapies for the treatment of glaucoma, corneal disorders and retinal diseases, today announced financ…
Eye Health America Announces Strategic Partnership with Bowden Eye & Associates, Expanding Presence into Eastern Florida
JACKSONVILLE, Fla.–(BUSINESS WIRE)–Eye Health America (EHA), a leading integrated eyecare platform in the Southeastern United States, is pleased to announce its strategic partnership with Bowden Eye & Associates, a renowned ophthalmology practice…
20/20 Onsite Executives Recognized for Global Business Achievements in the 2024 TITAN Women In Business Awards
BOSTON–(BUSINESS WIRE)–20/20 Onsite is proud to announce that two of its executives, Sonali Bloom, CEO, and Jessica McKenzie Mays, Vice President of Life Sciences, have been named 2024 Female Executives of the Year by the TITAN Women in Business Awar…
FELIQS Receives U.S. FDA Fast Track Designation for FLQ-101, a First-in-class Small Molecule to Prevent Retinopathy of Prematurity
FUKUOKA, Japan & NEW YORK–(BUSINESS WIRE)–FELIQS®, a clinical stage multinational biopharmaceutical company focused on the development of first-in-class small molecules targeting lipid oxidation, announced today that the U.S. Food and Drug Administra…
Harrow To Report Third Quarter 2024 Financial Results After Market Close on November 13, 2024
NASHVILLE, Tenn.–(BUSINESS WIRE)—- $HROW–Harrow (Nasdaq: HROW), a leading North American eyecare pharmaceutical company, today announced that it will report its financial results for the third quarter ended September 30, 2024, on Wednesday, Novembe…
Aldeyra Therapeutics Selected to Present at the Disruptive Innovations Symposium during the OSN New York Retina 2024 Meeting
LEXINGTON, Mass.–(BUSINESS WIRE)–Aldeyra Therapeutics, Inc. (Nasdaq: ALDX) (Aldeyra), a biotechnology company devoted to discovering and developing innovative therapies designed to treat immune-mediated and metabolic diseases, today announced that To…
Merck Announces Third-Quarter 2024 Financial Results
RAHWAY, N.J.–(BUSINESS WIRE)–Merck Announces Third-Quarter 2024 Financial Results
STAAR Surgical Reports Third Quarter 2024 Results
LAKE FOREST, Calif.–(BUSINESS WIRE)–STAAR Surgical Company (NASDAQ: STAA), a leading developer, manufacturer and marketer of the EVO family of Implantable Collamer® Lenses (EVO ICL™) for myopia, astigmatism and presbyopia, today reported financial re…
Scripps Research Advances Breakthrough Regenerative Medicines to Reverse Aging-Related Diseases
LA JOLLA, Calif.–(BUSINESS WIRE)–As people live longer than ever before, the incidence of aging-related, chronic diseases is on the rise, severely impacting quality of life and placing an unprecedented financial and care burden on overwhelmed familie…
Scripps Research Advances Breakthrough Regenerative Medicines to Reverse Aging-Related Diseases
LA JOLLA, Calif.–(BUSINESS WIRE)–As people live longer than ever before, the incidence of aging-related, chronic diseases is on the rise, severely impacting quality of life and placing an unprecedented financial and care burden on overwhelmed familie…
Bausch + Lomb Announces Third-Quarter 2024 Results
VAUGHAN, Ontario–(BUSINESS WIRE)–Bausch + Lomb Corporation (NYSE/TSX: BLCO), a leading global eye health company dedicated to helping people see better to live better, today announced its third-quarter 2024 financial results. “Our focus on execution …
Acute Ocular Pain Market Analysis, Opportunities and Forecasts, 2020-2024 & 2025-2030 by Source of Pain, Treatment Type, Sales Channel, Region, and Country – ResearchAndMarkets.com
DUBLIN–(BUSINESS WIRE)–The “Global Acute Ocular Pain Market (2024 Edition): Market Size, Trends, Opportunities and Forecast by Source of Pain, Treatment Type, Sales Channel, Region, By Country: 2020-2030” report has been added to ResearchAndMarkets.c…
NovaBay Pharmaceuticals Board Determines Unsolicited Offer is Superior to Asset Purchase Agreement with PRN Physician Recommended Nutriceuticals, LLC
EMERYVILLE, Calif.–(BUSINESS WIRE)–NovaBay® Pharmaceuticals, Inc. (NYSE American: NBY) (“NovaBay” or the “Company”) announces that the Company’s board of directors has determined that an unsolicited and non-binding offer from Refresh Acquisitions Bid…
Lumicell’s LumiSystem™ Featured on Viewpoint with Dennis Quaid for New Episode on Fluorescence-Imaging Guidance During Lumpectomy Surgery
NEWTON, Mass.–(BUSINESS WIRE)– #LUMISIGHT–Lumicell’s LumiSystem™ Featured on Viewpoint with Dennis Quaid for New Episode on Fluorescence-Imaging Guidance During Lumpectomy Surgery
GenSight Biologics Announces Publication of Meta-Analyses Showing Better Outcomes for ND4-LHON Patients Treated with LUMEVOQ®
PARIS–(BUSINESS WIRE)–Regulatory News: GenSight Biologics (Euronext: SIGHT, ISIN: FR0013183985, PEA-PME eligible), a biopharma company focused on developing and commercializing innovative gene therapies for retinal neurodegenerative diseases and cent…
Alcon Singapore Elevates Associate Experience with Inspiring Engagement Programs
SINGAPORE–(BUSINESS WIRE)–Alcon, the global leader in eye care dedicated to helping people see brilliantly, today announced that it has been named one of the ‘Best Employers in Singapore’ for the second consecutive year in addition to its recognition…
GenSight Biologics Reports Cash Position as of September 30, 2024, and Provides Business Update
PARIS–(BUSINESS WIRE)–Regulatory News: GenSight Biologics (“GenSight Biologics” or the “Company”) (Euronext: SIGHT, ISIN: FR0013183985, PEA-PME eligible), a biopharma company focused on developing and commercializing innovative gene therapies for ret…
Get Hooked on Maui Jim’s New Fishing Style, Keha
PEORIA, Ill.–(BUSINESS WIRE)–Maui Jim set sail on a fishing adventure with the launch of its first activity-specific performance-inspired sport style, Keha 663 and its Asian Fit counterpart Keha Asian Fit 664, on October 8. This quintessential 8-base…
Cellino Appoints Chris Gibson to Board of Directors
CAMBRIDGE, Mass.–(BUSINESS WIRE)– #biomanufacturing–Cellino Appoints Chris Gibson to Board of Directors